retatrutide dosing trial VisualAbstract: reduces body weight by 17.5% in patients with obesity Retatrutide Weight Loss Study: High

Fedme er for mange en kronisk sykdom med vedvarende forstyrrelser i mekanismene som kontrollerer kroppsvekten

Every missed dose is wasted money

If youve got severe obesity and severe OSA and youre not an ideal MMA candidate right now, a course of GLP-1 therapy followed by surgical evaluation is a reasonable path

Remember the observations on the FDA 483 are just the investigators opinions

GLP-1 receptors are in the pancreas and in other tissues including the gut and brain, so effects extend beyond glucose control to appetite centers and peripheral tissues related to metabolism

Take control of your health journey contact us today